Integra LifeSciences | IART - Loan Capital


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Integra LifeSciences

Integra LifeSciences reported $1.44B in Loan Capital for its fiscal quarter ending in March of 2023.


Loan Capital Change
Abbott ABT:US USD 14.62B 93M
Baxter International BAX:US USD 15.28B 46M
Becton, Dickinson and Co. BDX:US USD 16.01B 1.74B
Cooper Companies COO:US USD 2.63B 276.5M
Dexcom DXCM:US USD 1.26B 400K
Edwards Lifesciences EW:US USD 596.5M 200K
Hologic HOLX:US USD 2.81B 9.2M
Insulet PODD:US USD 1.37B 5.5M
Integra LifeSciences IART:US USD 1.44B 34.52M
J&J JNJ:US USD 34.93B 8.04B
Merit Medical Systems MMSI:US USD 186.42M 336K
NuVasive NUVA:US USD 445.84M 765K
Smith & Nephew PLC SN/:LN 2.71B 431M
Stryker SYK:US USD 11.86B 0
Tandem Diabetes Care TNDM:US USD 283.68M 447K
Teleflex TFX:US USD 1.55B 74.55M
Zimmer Biomet Holdings Inc ZBH:US USD 5.2B 52.6M